Insulin infusion pilot study
Contemporary Nurse
|October 9, 1999
Abstract:
To help resolve debate as to the relative efficacy of two different insulin delivery media, we set out to examine differences between Haemaccel and Normal Saline with reference to our hospital's current infusion procedures. After analysing the data, we found that there was a statistically significant difference between Haemaccel and Normal Saline and that, for solutions containing one unit of soluble insulin per ten mls of carrier solution, Haemaccel was the carrier of choice and clearly indicated as the preferable medium in acute diabetic situations like DKA and HHNKC.
Related Concept Videos
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:27Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...